


| Key | % Net Assets |
|---|---|
| 6.8% | |
| 6.0% | |
| 5.9% | |
| 5.1% | |
| 76.2% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 6.8% |
| Royal Dutch Shell | 6.0% |
| Unilever | 5.9% |
| BG Group | 5.1% |
| Vodafone | 5.0% |
| HSBC Holdings | 4.4% |
| BP | 4.4% |
| Anglo American | 4.2% |
| AstraZeneca | 3.7% |
| Centrica | 3.3% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 572.40p |
| Currency | GBP |
| Change | 0.60p |
| % | 0.10% |
| YTD change | 61.90p |
| YTD % | 12.13% |
| Fund Inception | 06/05/1997 |
|---|---|
| Fund Manager | Jeremy Smith |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £1000000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.09 |
You are here: research